Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Eli Lilly’s Lackluster Pipeline + Premium Valuation = Goldman Sachs Downgrade
Barron's
Monday, November 11, 2013 - 2:19pm
tags:
Eli Lilly
Alnylam rises as FDA bestows fast-track status
Yahoo/AP
Monday, November 11, 2013 - 2:13pm
tags:
fast track, Alnylam, FDA, Patisiran
How Much? A Battle Over The Cost Of The New Hepatitis C Drugs
Pharmalot
Monday, November 11, 2013 - 11:40am
tags:
hepatitis C, drug pricing, sofosbuvir, FDA, Gilead Sciences
Why Doctors, Dialysis Providers And Investors Are Excited About Zerenex
Seeking Alpha
Monday, November 11, 2013 - 11:39am
tags:
dialysis, Zerenex, Keryx
Crunch time for GlaxoSmithKline's big heart drug bet
Yahoo/Reuters
Monday, November 11, 2013 - 10:45am
tags:
GSK, darapladib
Zalicus drops pain drug after trial failures
Yahoo/Reuters
Monday, November 11, 2013 - 10:38am
tags:
Zalicus, painkillers, Z160
Small Esperion Vs Pharma Giants In The Cholesterol Race
Seeking Alpha
Monday, November 11, 2013 - 10:35am
tags:
Esperion Therapeutics, ETC-1002, Sanofi, Regeneron, Amgen, Pfizer, Roche
Is Eisai Making A Down Payment On Arena?
Seeking Alpha
Monday, November 11, 2013 - 10:29am
tags:
Eisai, Arena Pharmaceuticals, Belviq
Galena: Initial Abstral Sales Ramp Bodes Well For Successful Launch
Yahoo/Zacks.com
Monday, November 11, 2013 - 10:22am
tags:
Abstral, Galena Biopharma
Novartis sells blood transfusion test unit to Grifols for $1.7 billion
Yahoo/Reuters
Monday, November 11, 2013 - 10:21am
tags:
Novartis, M&A, blood transfusions, Grifols
Can Orexigen Therapeutics Catch Up With Arena Pharmaceuticals and VIVUS?
Motley Fool
Monday, November 11, 2013 - 10:19am
tags:
Arena Pharmaceuticals, Vivus, obesity, Orexigen, Contrave, Belviq, Qsymia
Will Dendreon Catch Johnson & Johnson or Fall Behind Celldex?
Motley Fool
Monday, November 11, 2013 - 10:17am
tags:
Dendreon, JNJ, Celldex
Shire Buys ViroPharma for $4.2 Billion to Add Orphan Drug
Bloomberg
Monday, November 11, 2013 - 10:16am
tags:
ViroPharma, Shire, M&A
Will Biosimilars Unlock This Company's Long-Term Potential?
Daily Finance
Sunday, November 10, 2013 - 1:51pm
tags:
biosimilars, generics, Hospira
Pfizer And Merck Continue To Battle Declining Revenue
Seeking Alpha
Sunday, November 10, 2013 - 1:26pm
tags:
Pfizer, Merck
Is This Cubist's Biggest Opportunity?
Motley Fool
Sunday, November 10, 2013 - 1:22pm
tags:
Cubist Pharmaceuticals, antibiotics, antibiotic resistance
ModernGraham Valuation Of Johnson & Johnson
Seeking Alpha
Sunday, November 10, 2013 - 1:19pm
tags:
JNJ
Will Merck Be Able To Reward Its Shareholders?
Seeking Alpha
Sunday, November 10, 2013 - 1:17pm
tags:
Merck
Merck’s Investigational Grass Sublingual Allergy Immunotherapy Tablet Significantly Reduced Allergy Symptoms and Need for Symptom-Relief Medication in Adults and Children in Pivotal Phase III Study
Yahoo/BusinessWire
Sunday, November 10, 2013 - 1:13pm
tags:
Merck, immunotherapy, MK-7243, allergies
Can Arena's Obesity Handoff Create a Touchdown?
Motley Fool
Sunday, November 10, 2013 - 1:10pm
tags:
Arena Pharmaceuticals, Eisai, obesity, weight loss, Belviq

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.